Asia Green Biotechnology Corp. (ASIA.CN) Research

Asia Green Biotechnology Corp. is an emerging international biotechnology firm dedicated to researching, developing, testing, and distributing products. These offerings leverage the company's proprietary organic hybridization technology, with its primary application focused in Asia. A key aspect of their operations involves the cultivation and harvesting of novel and commercially valuable strains of hemp and similar crops. The company has forged strategic alliances with Pathway Rx Inc. and PNW Biosciences Inc. to advance the clinical development and market introduction of specific Cannabis sativa varieties. These varieties are being explored for their potential in both preventing and treating COVID-19 and other infectious ailments. Established in 2017, the organization was originally named Asia Cannabis Corp. It adopted its current moniker, Asia Green Biotechnology Corp., in April 2020. Its corporate headquarters are located in Calgary, Canada.

Market snapshot

Symbol
ASIA.CN
Price
$0.02
Day change
0.00%
Market cap
$543.7K
P/E ratio
-2.46x
52-week range
0.015-0.015
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Agra Ventures Ltd. (AGRA.CN)
  • Biome Grow Inc. (BIO.CN)
  • Camarico Investment Group Ltd. (CIG.CN)
  • Global Hemp Group Inc. (GHG.CN)
  • Hempsana Holdings Ltd. (HMPS.CN)
  • Lords & Company Worldwide Holdings Inc. (LRDS.CN)
  • Levitee Labs Inc. (LVT.CN)
  • Medcolcanna Organics Inc. (MCCN.CN)

Open Asia Green Biotechnology Corp. (ASIA.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.